Company / Capital Expenditures
MEDIFAST INC Capital Expenditures History
FY2014-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$5.6M
FY2025
5-year range
$3.2M / $7.5M
FY2021-FY2025
Trend
-24.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Capital Expenditures has fluctuated over the past 10 years, ranging from $3M in FY2017 to $11M in FY2015.
Based on SEC 10-K filings.
$6M in FY2025 with a 10-year CAGR of -6.8%.
Declined from $6M to $6M over the past 2 years.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- +2.6%
- 10-Year CAGR
- -6.8%
Key checks
Key Insights
- 5-year CAGR of +2.6%, indicating consistent growth.
- In FY2025, capital expenditures decreased 24.7% year-over-year.
- Peak capital expenditures was recorded in FY2015.
- Lowest capital expenditures in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score 4.08 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $5.6M | -24.7% |
| FY2024 | $7.5M | +15.0% |
| FY2023 | $6.5M | +31.2% |
| FY2020 | $4.9M | +52.4% |
| FY2019 | $3.2M | +12.7% |
| FY2018 | $2.9M | +2.0% |
| FY2017 | $2.8M | -59.9% |
| FY2016 | $7.0M | -38.3% |
| FY2015 | $11.4M | +40.1% |
| FY2014 | $8.1M | -43.1% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026